City

Albuquerque (1)

Charlottesville (1)

Cleveland (1)

Iowa City (1)

Oklahoma City (1)

Philadelphia (1)

Pittsburgh (1)

Providence (1)

Seattle (1)

Condition

Recurrent Endometrial Adenocarcinoma (1)

Recurrent Endometrial Carcinoma (1)

Recurrent Endometrial Clear Cell Adenocarcinoma (1)

Recurrent Endometrial Dedifferentiated Carcinoma (1)

Recurrent Endometrial Endometrioid Adenocarcinoma (1)

Recurrent Endometrial Mixed Cell Adenocarcinoma (1)

Recurrent Endometrial Mucinous Adenocarcinoma (1)

Recurrent Endometrial Undifferentiated Carcinoma (1)

Recurrent Endometrioid Adenocarcinoma (1)

Overall Status

Recruiting (1)

Phase

phase 2 (1)

Sponsor

National Cancer Institute (NCI) (1)

Collaborator

NRG Oncology (1)

Intervention

ipilimumab (1)

nivolumab (1)

Study Documents

Intervention Type

biological (1)

Funder Type

NIH (1)

Study Type

Interventional (1)

recurrent endometrial mucinous adenocarcinoma

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Recurrent Endometrial Adenocarcinoma, Recurrent Endometrial Carcinoma, Recurrent Endometrial Clear Cell Adenocarcinoma Trial in

Recruiting

Recurrent Endometrial Adenocarcinoma
+8 more

Ipilimumab
Nivolumab

Iowa City, Iowa
+9 more

Jan 27, 2023